Deals & Cases

Schellenberg Wittmer advised Boehringer Ingelheim on its acquisition of Saiba Animal Health

05.09.2024

Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Saiba Animal Health AG.

Saiba Animal Health AG is focused on the development of novel therapeutic medicines to address chronic diseases in pets.

Our team consisted of Pascal Hubli (overall lead), Elia Schunck, Olivia Wipf, Mario Schwager and Anna Wöller (Corporate/M&A), Philipp Groz and Alisa Zehner (Intellectual Property), Michael Hess and Ruba Kassem (Employment) as well as Michael Nordin and Tabea Elmer (Taxation).

 

Stay up to date!

*Required fields

Newsletters & Newsflashes

Monthly selected key topics from our practice areas, sectors and industries, plus newsflashes on recent developments.

Publications

Monthly email with the latest updates and summaries of the Swiss Federal Supreme Court's case law in arbitration matters.
Regular insights into Swiss and international trends and legal developments in the construction industry.
Regular insights and updates on key developments in the rapidly changing landscape of Environmental, Social and Corporate Governance disputes.
Concise analysis of key trends in the fast-moving world of corporate governance for board members of Swiss companies.
A regular look from a unique M&A perspective at legal changes, economic developments and societal trends in Switzerland.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.